{"id":"NCT03835975","sponsor":"Pfizer","briefTitle":"Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination","officialTitle":"A PHASE 3, RANDOMIZED, OPEN-LABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A 20-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN ADULTS â‰¥65 YEARS OF AGE WITH PRIOR PNEUMOCOCCAL VACCINATION","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-02-12","primaryCompletion":"2020-02-12","completion":"2020-02-12","firstPosted":"2019-02-11","resultsPosted":"2021-02-21","lastUpdate":"2021-02-21"},"enrollment":875,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Pneumococcal Disease"],"interventions":[{"type":"BIOLOGICAL","name":"13vPnC","otherNames":[]},{"type":"BIOLOGICAL","name":"PPSV23","otherNames":[]},{"type":"BIOLOGICAL","name":"20vPnC","otherNames":[]}],"arms":[{"label":"13vPnC","type":"ACTIVE_COMPARATOR"},{"label":"PPSV23","type":"ACTIVE_COMPARATOR"},{"label":"20vPnC","type":"EXPERIMENTAL"}],"summary":"This Phase 3 will describe the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine formulation in adults 65 years of age or older with prior pneumococcal vaccination","primaryOutcome":{"measure":"Percentage of Participants With Local Reactions Within 10 Days After Vaccination","timeFrame":"Within 10 days after vaccination","effectByArm":[{"arm":"Cohort A: 20vPnC","deltaMin":7.9,"sd":null},{"arm":"Cohort A: 13vPnC","deltaMin":2.5,"sd":null},{"arm":"Cohort B: 20vPnC","deltaMin":8.6,"sd":null},{"arm":"Cohort B: PPSV23","deltaMin":12.7,"sd":null},{"arm":"Cohort C: 20vPnC","deltaMin":4.8,"sd":null}],"pValues":[]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":42,"countries":["United States","Sweden"]},"refs":{"pmids":["34839993"],"seeAlso":["https://pmiform.com/clinical-trial-info-request?StudyID=B7471006"]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":253},"commonTop":["Injection site pain (PAIN)","Myalgia (MUSCLE PAIN)","Fatigue (FATIGUE)","Headache (HEADACHE)","Arthralgia (JOINT PAIN)"]}}